155 related articles for article (PubMed ID: 11486699)
21. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.
Amantea MA; Forrest A; Northfelt DW; Mamelok R
Clin Pharmacol Ther; 1997 Mar; 61(3):301-11. PubMed ID: 9084455
[TBL] [Abstract][Full Text] [Related]
22. Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma using bleomycin-containing combination chemotherapy regimens.
Ireland-Gill A; Espina BM; Akil B; Gill PS
Semin Oncol; 1992 Apr; 19(2 Suppl 5):32-6; discussion 36-7. PubMed ID: 1384142
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness analysis comparing chemotherapy regimens in the treatment of AIDS-related Kaposi's sarcoma in Brazil.
Vanni T; Fonseca BA; Polanczyk CA
HIV Clin Trials; 2006; 7(4):194-202. PubMed ID: 17065031
[TBL] [Abstract][Full Text] [Related]
24. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
Gill PS; Bernstein-Singer M; Espina BM; Rarick M; Magy F; Montgomery T; Berry MS; Levine A
AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520
[TBL] [Abstract][Full Text] [Related]
25. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
[TBL] [Abstract][Full Text] [Related]
26. Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
Goebel FD; Jablonowski H
Eur J Med Res; 1999 Dec; 4(12):507-13. PubMed ID: 10611054
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W
Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
[TBL] [Abstract][Full Text] [Related]
28. New treatment for KS offers options for therapy.
AIDS Alert; 1996 Feb; 11(2):21-2. PubMed ID: 11363236
[TBL] [Abstract][Full Text] [Related]
29. Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin.
Hengge UR; Esser S; Rudel HP; Goos M
Eur J Cancer; 2001 May; 37(7):878-83. PubMed ID: 11313176
[TBL] [Abstract][Full Text] [Related]
30. Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma.
Zhong DT; Shi CM; Chen Q; Huang JZ; Liang JG; Lin D
J Cancer Res Clin Oncol; 2012 Mar; 138(3):425-30. PubMed ID: 22160130
[TBL] [Abstract][Full Text] [Related]
31. Raynaud phenomenon in three patients with acquired immune deficiency syndrome-related Kaposi sarcoma treated with bleomycin.
von Gunten CF; Roth EL; Von Roenn JH
Cancer; 1993 Sep; 72(6):2004-6. PubMed ID: 7689922
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary Kaposi's sarcoma in AIDS patients treated with combined chemotherapy and recombinant human granulocyte colony-stimulating factor.
Mastroianni A; Coronado O; Cancellieri C; Manfredi R; Pignatari S; Chiodo F
J Chemother; 1998 Oct; 10(5):405-10. PubMed ID: 9822360
[TBL] [Abstract][Full Text] [Related]
33. Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma.
Cadranel JL; Kammoun S; Chevret S; Parrot A; Denis M; Winter C; Carette MF; Rozenbaum W; Akoun GM; Mayaud CM
Thorax; 1994 Oct; 49(10):958-60. PubMed ID: 7526480
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.
Cianfrocca M; Lee S; Von Roenn J; Tulpule A; Dezube BJ; Aboulafia DM; Ambinder RF; Lee JY; Krown SE; Sparano JA
Cancer; 2010 Aug; 116(16):3969-77. PubMed ID: 20564162
[TBL] [Abstract][Full Text] [Related]
35. Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma.
Simpson JK; Miller RF; Spittle MF
Clin Oncol (R Coll Radiol); 1993; 5(6):372-4. PubMed ID: 8305358
[TBL] [Abstract][Full Text] [Related]
36. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS
Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
[TBL] [Abstract][Full Text] [Related]
37. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences.
Wagner D; Kern WV; Kern P
Clin Investig; 1994 Jun; 72(6):417-23. PubMed ID: 7950152
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Outcomes in AIDS-Associated Kaposi's Sarcoma Patients on Antiretroviral Therapy Treated with Chemotherapy at Two Tertiary Hospitals in Lusaka, Zambia.
Mtonga W; Mujajati A; Munkombwe D; Kalungia A; Muungo LT; West J; Wood C; Ngalamika O
Curr HIV Res; 2018; 16(3):231-236. PubMed ID: 29992888
[TBL] [Abstract][Full Text] [Related]
39. [Kaposi's sarcoma].
Imamura A
Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
[TBL] [Abstract][Full Text] [Related]
40. Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma.
Sharpe M; Easthope SE; Keating GM; Lamb HM
Drugs; 2002; 62(14):2089-126. PubMed ID: 12269857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
